BAMA
Evaluation of a Cardiac Care Solution for Post-Hospital Management in Primary and Secondary Care of Patients Diagnosed With Coronary Artery Disease
Sponsor study identifier
interventional
300
1 country
1
Study Start
April 8, 2016
Actual (reported)Primary Completion
July 30, 2018
Actual (reported)Study Completion
July 30, 2018
Actual (reported)This is a prospective, randomized controlled trial. The aim of the study is to evaluate the impacts of a cardiac post-discharge management solution in the secondary prevention of Coronary Artery Disease (CAD).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 3, 2016
Actual (reported)April 8, 2016
Actual (reported)June 21, 2018
Actual (reported)July 30, 2018
Actual (reported)July 30, 2018
Actual (reported)Compliance for coronary heart disease secondary prevention at 12 months
Proportion of patients who use standardized secondary prevention medication according to current guidelines.
12 months
Medication compliance at the 6, 12 months using the MMAS-8 (The eight-item Morisky Medication Adherence Scale)
6 and 12 months
Control rates of risk factors at the 6, 12 months
6 and 12 months
Quality of life at the 6, 12 months (EQ-5D simple score)
6 and 12 months
Quality of life at the 6, 12 months (EQ-5D Visual Analog Score)
6 and 12 months
Quality of life at the 6, 12 month (Seattle angina questionnaire)
6 and 12 months
This group will use BAMA solution. This is an digital solution used for cardiac post-discharge management. It is an application installed on a tablet. This arm will use this application and also have usual outpatient follow up.
Not using the application installed on the tablet. Usual outpatient follow up.
Use of BAMA cardiac post-discharge management solution for patients education and follow up management
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Division of Cardiology, Peking University First Hospital
Beijing, 100034, China
Li Y, Gong Y, Zheng B, Fan F, Yi T, Zheng Y, He P, Fang J, Jia J, Zhu Q, Jiang J, Huo Y. Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2022 Feb 15;10(2):e32251. doi: 10.2196/32251.
Yong Huo, MD
Peking University First Hospital
First Submitted
April 3, 2016
First Posted
June 21, 2018
Study Start
April 8, 2016
Actual (reported)Primary Completion
July 30, 2018
Actual (reported)Contact the study team to confirm eligibility.
Study Completion
July 30, 2018
Actual (reported)Last Updated
March 5, 2020
Record last verified: 2020-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: